论文信息 - Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO - 字舞流文

Upfront Modified Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Panitumumab Versus Fluorouracil, Leucovorin, and Oxaliplatin Plus Panitumumab for Patients With RAS/BRAF Wild-Type Metastatic Colorectal Cancer: The Phase III TRIPLETE Study by GONO

G. Fontanini | L. Antonuzzo | L. Boni | M. Aglietta | S. Murgioni | D. Rossini | V. Formica | G. Masi | A. Buonadonna | S. Lonardi | F. Morano | F. Pietrantonio | G. Aprile | C. Cremolini | C. Pozzo | F. Bergamo | G. Randon | V. Conca | C. Antoniotti | R. Bordonaro | R. Moretto | A. Passardi | F. Marmorino | A. Boccaccino | B. Borelli | M. Giordano | E. Tamburini | M. Brugia